Teneobio
ClosedNewark, United States · $30.0M raised
- Headquarters
- Newark, California
- Employees
- 51–200
- Business Model
- B2B
- Website
- teneobio.com
- Total Funding
- $30.0M
- Last Round
- $30.0M Series AMar 2016
- Rounds
- 1
About
Clinical-stage biotech developing UniAb human heavy-chain antibodies as a new class of biologics for disease treatment.
Summary
Teneobio is a Biotech company based in Newark, United States. It has raised $30.0M in total across 1 round, most recently a $30.0M Series A round in Mar 2016. Investors include AstraZeneca, Amgen and Lightspeed VP.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2022
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...